Towards an ideal economic clinical trial

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.401, 2003-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical and Economic Outcomes of Olanzapine Compared With Haloperidol for Schizophrenia: Results From a Randomised Clinical Trial

By Hamilton S.H.  

PharmacoEconomics, Vol. 15, Iss. 5, 1999-05 ,pp. : 469-480

Adis International

Access to resources Recommend Favorite

Adjuvant Trastuzumab for Breast Cancer: Uncertainties in Clinical and Economic Evidence Following Early Stopping of the HERA Trial

By Younis Tallal   Skedgel Chris  

PharmacoEconomics, Vol. 29, Iss. 5, 2011-05 ,pp. : 361-365

Adis International

Access to resources Recommend Favorite

Economic Evaluations During Early (Phase II) Drug Development: A Role for Clinical Trial Simulations?

By Hughes D.A.   Walley T.  

PharmacoEconomics, Vol. 19, Iss. 11, 2001-11 ,pp. : 1069-1077

Adis International

Access to resources Recommend Favorite

Economic Impact of Increased Clinical Intervention Rates in Community Pharmacy: A Randomised Trial of the Effect of Education and a Professional Allowance

By Benrimoj S.I.  

PharmacoEconomics, Vol. 18, Iss. 5, 2000-11 ,pp. : 459-468

Adis International

Access to resources Recommend Favorite

Arzoxifene: the development and clinical outcome of an ideal SERM

By Munster Pamela N  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 3, 2006-03 ,pp. : 317-326

Informa Healthcare

Access to resources Recommend Favorite